Table 1.
Patient and Tumor Characteristics (N=150)
| Variable | Control Group | Cirrhosis Group | HCC Group |
|---|---|---|---|
| Case, n | 50 | 50 | 50 |
| Age | 60.5±7.8 | 62.0±9.6 | 62.8±8.1 |
| Sex | |||
| Female | 19 | 19 | 17 |
| Male | 31 | 31 | 33 |
| HBsAg | |||
| Positive | 0 | 36 | 43 |
| Negative | 50 | 14 | 7 |
| HBeAg | |||
| Positive | 0 | 34 | 40 |
| Negative | 50 | 16 | 10 |
| Liver cirrhosis | |||
| Yes | 0 | 50 | 50 |
| No | 50 | 0 | 0 |
| TBL (µmol/l) | 12.5±8.3 | 15.1±7.3 | 16.1±8.2 |
| ALB (g/dl) | 39.4±6.6 | 38.9±6.5 | 37.9±4.6 |
| ALT (U/L) | 25.7±14.1 | 50.4±30.2 | 79.4±66.5 |
| AFP at diagnosis (ng/mL) | |||
| ≤400 | 50 | 42 | 32 |
| >400 | 0 | 8 | 18 |
| Tumor size (cm) | |||
| >5 cm | _ | _ | 23 |
| ≤5 cm | _ | _ | 27 |
| Microvascular invasion | |||
| Yes | _ | _ | 20 |
| No | _ | _ | 30 |
| TNM staging | |||
| I | _ | _ | 10 |
| II | _ | _ | 7 |
| III–IV | _ | _ | 33 |
| Metastases | |||
| Yes | _ | _ | 21 |
| No | _ | _ | 29 |
| Treatment | |||
| Target therapy | _ | _ | 30 |
| Chemotherapy | _ | _ | 8 |
| Partial hepatectomy | _ | _ | 6 |
| Anatomical liver resection | _ | _ | 6 |
Abbreviations: TBL, total bilirubin; ALB, albumin; ALT, alanine aminotransferase; AFP, alpha-fetoprotein; HBV, hepatitis B virus.